Research programme: pain therapeutics - Neorphys

Drug Profile

Research programme: pain therapeutics - Neorphys

Alternative Names: Neo-1507; Neo-1509; Neo-1528; Neo-15xx

Latest Information Update: 12 Jul 2016

Price : $50

At a glance

  • Originator Neorphys
  • Class Analgesics; Morphinans
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 12 Jul 2016 Discontinued - Preclinical for Pain in France (unspecified route)
  • 22 Jan 2010 Preclinical trials in Pain in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top